Notas de prensa

  • 21 de septiembre de 2017
  • 201

Envigo appoints Chief Commercial Officer and President of EMEA Operations

Princeton, NJ, September 21, 2017: Envigo announced today that it has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo.

Craig Boyd has joined Envigo in the position of Chief Commercial Officer.

Craig has more than 20 years’ experience in various global pharmaceutical markets and has worked extensively in the US, Asia, Europe and Australia. A dynamic commercial leader, Craig was the Executive Vice President of Mayne Pharma’s US specialty brands division before joining Envigo.  Prior to this, Craig led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis. In his new role, Craig is responsible for Envigo’s global commercial organization, including, sales, marketing, pricing and customer service activities. 


Lizanne Muller has joined Envigo as President EMEA Operations.

Lizanne has 18 years’ experience working within a multinational pharmaceutical manufacturing company, and brings with her extensive commercial experience, specializing in operational finance, continuous improvements, regulatory compliance and change management. Prior to joining Envigo, Lizanne spent 16 years at the Dishman Group serving in a variety of roles of increasing responsibility including Vice President of Compliance and Governance. Lizanne is accountable for Envigo’s Contract Research Services and Research Services Models operations across Europe and Asia.


"I am delighted that Craig and Lizanne have joined the team at Envigo and both brought with them great experience and knowledge that has added huge value to the way we work", commented Adrian Hardy. "Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

Destacadas

  • Investigadores de la Fundación IOR demuestran que  combinar cetuximab con fármacos orales mejora la  respuesta del cáncer de pulmón con KRAS mutado

    Patricia Morén

    Investigadores de la Fundación IOR demuestran que combinar cetuximab con fármacos orales mejora la respuesta del cáncer de pulmón con KRAS mutado

    Leer más
  • Asociaciones de pacientes de 7 países, entre ellos España, elaboran el primer consenso global para la mejora del diagnóstico y el cuidado de los pacientes con Linfoma Cutáneo

    Alba Martín

    Asociaciones de pacientes de 7 países, entre ellos España, elaboran el primer consenso global para la mejora del diagnóstico y el cuidado de los pacientes con Linfoma Cutáneo

    Leer más
  • El ejercicio físico mejora la adherencia al tratamiento nutricional y el control de la enfermedad de los pacientes con PKU

    Alba Martín

    El ejercicio físico mejora la adherencia al tratamiento nutricional y el control de la enfermedad de los pacientes con PKU

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España